Altris AI (Altris, Inc) is a company which applies computer vision and deep learning trained algorithms to build innovative ophthalmology diagnosis real-time support platform for the automatic, structural and quantitative analysis and detection of glaucoma, age-related macular degeneration, diabetic retinopathy and other retinal diseases on Optical Coherence Tomography (OCT) scans by learning from a large dataset of clinical cases.
The company has accumulated and legally owns one of the most massive anonymized databases of the retina, optic nerve scans, and images as well as clinical data. We continue increasing our dataset daily in our ophthalmology center with OCT, OCT-Angio scans.
Altris AI’s OCT algorithms have been trained using anonymized OCT retinal scans collected during more than 12 years and are able to detect more than 100 pathological signs, retinal diseases and conditions. Currently, Altris AI’s solution is available in web and mobile version for structural retina analysis. The model shows the high level of performance with multi-disease classification accuracy more than 96%.